PL3280430T3 - Peptyd QBP1 do stosowania w zapobieganiu lub leczeniu zespołu stresu pourazowego, ostrego zaburzenia stresowego oraz ogólnego zespołu adaptacyjnego - Google Patents
Peptyd QBP1 do stosowania w zapobieganiu lub leczeniu zespołu stresu pourazowego, ostrego zaburzenia stresowego oraz ogólnego zespołu adaptacyjnegoInfo
- Publication number
- PL3280430T3 PL3280430T3 PL16725038T PL16725038T PL3280430T3 PL 3280430 T3 PL3280430 T3 PL 3280430T3 PL 16725038 T PL16725038 T PL 16725038T PL 16725038 T PL16725038 T PL 16725038T PL 3280430 T3 PL3280430 T3 PL 3280430T3
- Authority
- PL
- Poland
- Prior art keywords
- syndrome
- qbp1
- peptide
- prevention
- post
- Prior art date
Links
- 230000037328 acute stress Effects 0.000 title 1
- 230000011923 general adaptation syndrome Effects 0.000 title 1
- 208000028173 post-traumatic stress disease Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15382176.4A EP3078383A1 (en) | 2015-04-10 | 2015-04-10 | Use of qbp1 peptide for the inhibition of memory consolidation |
| PCT/EP2016/057801 WO2016162506A1 (en) | 2015-04-10 | 2016-04-08 | Use of qbp1 peptide for the inhibition of memory consolidation |
| EP16725038.0A EP3280430B1 (en) | 2015-04-10 | 2016-04-08 | Qbp1-peptide for use in the prevention or treatment of post-traumatic stress disorder, acute stress syndrome and general adaptation syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3280430T3 true PL3280430T3 (pl) | 2020-12-14 |
Family
ID=52875651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16725038T PL3280430T3 (pl) | 2015-04-10 | 2016-04-08 | Peptyd QBP1 do stosowania w zapobieganiu lub leczeniu zespołu stresu pourazowego, ostrego zaburzenia stresowego oraz ogólnego zespołu adaptacyjnego |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20180125921A1 (pl) |
| EP (2) | EP3078383A1 (pl) |
| ES (1) | ES2800073T3 (pl) |
| PL (1) | PL3280430T3 (pl) |
| PT (1) | PT3280430T (pl) |
| WO (1) | WO2016162506A1 (pl) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014136118A1 (en) * | 2013-03-08 | 2014-09-12 | New York Medical College | Treatment of post-traumatic stress disorder with melanocortin receptor antagonist |
-
2015
- 2015-04-10 EP EP15382176.4A patent/EP3078383A1/en not_active Withdrawn
-
2016
- 2016-04-08 EP EP16725038.0A patent/EP3280430B1/en active Active
- 2016-04-08 PL PL16725038T patent/PL3280430T3/pl unknown
- 2016-04-08 ES ES16725038T patent/ES2800073T3/es active Active
- 2016-04-08 WO PCT/EP2016/057801 patent/WO2016162506A1/en active Application Filing
- 2016-04-08 PT PT167250380T patent/PT3280430T/pt unknown
- 2016-04-08 US US15/565,409 patent/US20180125921A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016162506A1 (en) | 2016-10-13 |
| US20180125921A1 (en) | 2018-05-10 |
| EP3280430A1 (en) | 2018-02-14 |
| EP3078383A1 (en) | 2016-10-12 |
| PT3280430T (pt) | 2020-06-29 |
| EP3280430B1 (en) | 2020-04-08 |
| ES2800073T3 (es) | 2020-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279752B (en) | Polycyclic compounds and their use in the treatment of immune disorders | |
| GB2548873B (en) | Use of Cannabidiol in the Treatment of SturgeWeber Syndrome | |
| IL271503A (en) | Preparations and treatments for sleep disorders | |
| GB201411496D0 (en) | Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy | |
| SG10201913054TA (en) | Novel lactobacillus having various functions, and use thereof | |
| IL259570A (en) | Combined therapy and their uses and methods | |
| GB201621480D0 (en) | Use of cannabinoids in the treatment of angelman syndrome | |
| GB2588261B (en) | Apparatus, use of the apparatus and arrangement | |
| HUE062536T2 (hu) | Migrén megelõzése és kezelése | |
| PL3362449T3 (pl) | Pochodne sybiriliny do zastosowania do zapobiegania i/lub leczenia zaburzeń związanych z nekroptozą komórkową | |
| SG10202013034QA (en) | Compositions, devices, and methods for the treatment of alcohol use disorder | |
| HK1249851A1 (zh) | 使用聚維酮碘的普通感冒的治療和預防 | |
| ZA201604611B (en) | Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder | |
| IL279391A (en) | Use of MIR-92A or MIR-145 in the treatment of Engelmann syndrome | |
| HUE067036T2 (hu) | 2-hidroxibenzilamin alkalmazása pulmonális magas vérnyomás kezelésében és megelõzésében | |
| IL275875A (en) | Treatment and prevention of sleep disorders | |
| IL251880A0 (en) | Preparations for the treatment of acute, post-operative or chronic pain and methods of using them | |
| RS65173B1 (sr) | Kompozicija za prevenciju i/ili lečenje simptoma alergije | |
| EP3271464A4 (en) | Mirna mimetics and their use in treating sensory conditions | |
| EP3110453A4 (en) | Tmem100 peptides and variants thereof and their use in treating or preventing diseases or conditions | |
| ZA201904328B (en) | Composition, application thereof and treatment method | |
| PL3280430T3 (pl) | Peptyd QBP1 do stosowania w zapobieganiu lub leczeniu zespołu stresu pourazowego, ostrego zaburzenia stresowego oraz ogólnego zespołu adaptacyjnego | |
| IL271555A (en) | Combining its uses and treatments | |
| HK1255631A1 (zh) | 用於預防和治療睡眠障礙的藥物組合物 | |
| AU2017902338A0 (en) | Sleep Disorder Composition and Treatment Thereof |